MCQ#18

Question-Mark

Ipilimumab, Pembrolizumab and Nivolumab being used in melanoma treatment target:

a) Natural Killer cells

b) T-cell activating receptors

c) T-cell inhibitory receptors

d) B-cells

Click here for Answer

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s